Clinical Trial: A Study of NHL907 in Healthy Adult Participants

U.S., May 13 -- ClinicalTrials.gov registry received information related to the study (NCT07580924) titled 'A Study of NHL907 in Healthy Adult Participants' on April 29.

Brief Summary: The goal of this study is to evaluate the safety, tolerability and pharmacokinetics of NHL907 when administered as multiple oral doses in healthy adult participants.

Study Start Date: May, 2026

Study Type: INTERVENTIONAL

Condition: Healthy Adult Participants

Intervention: DRUG: NHL907

Investigational product NHL907

DRUG: Placebo

NHL907 matching placebo

Recruitment Status: NOT_YET_RECRUITING

Sponsor: NeuHyll AUS Pty Ltd

Published by HT Digital Content Services with permission from Health Daily Digest....